1467 related articles for article (PubMed ID: 33942541)
1. Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
Scala E; Fania L; Bernardini F; Calarco R; Chiloiro S; Di Campli C; Erculei S; Giani M; Giordano M; Panebianco A; Passarelli F; Trovè A; Verkhovskaia S; Russo G; Sgadari A; Didona B; Abeni D
Immun Inflamm Dis; 2021 Sep; 9(3):617-621. PubMed ID: 33942541
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
3. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.
Fernández-Lázaro D; Garrosa M
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696346
[TBL] [Abstract][Full Text] [Related]
4. A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
Najar Nobari N; Seirafianpour F; Mashayekhi F; Goodarzi A
Dermatol Ther; 2021 Jan; 34(1):e14662. PubMed ID: 33301232
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
Punyaratabandhu P; Chirachanakul P
J Dermatol; 2021 Jan; 48(1):14-20. PubMed ID: 33180327
[TBL] [Abstract][Full Text] [Related]
6. Severe urticarial rash as the initial symptom of COVID-19 infection.
Pagali S; Parikh RS
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074
[TBL] [Abstract][Full Text] [Related]
8. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.
Genovese G; Moltrasio C; Berti E; Marzano AV
Dermatology; 2021; 237(1):1-12. PubMed ID: 33232965
[TBL] [Abstract][Full Text] [Related]
9. Peculiar Histopathologic Feature of an Erythematous/Morbilliform Eruption in a COVID-19-Positive Patient.
Caputo V; Metze D; Bonoldi E; Merli M; Rongioletti F
Am J Dermatopathol; 2021 Dec; 43(12):962-964. PubMed ID: 34608003
[TBL] [Abstract][Full Text] [Related]
10. A 34-Year-Old Woman with a Diamniotic Dichorionic Twin Pregnancy Presenting with an Erythematous and Papular Skin Rash Associated with SARS-CoV-2 Infection.
Oropeza Chávez L; Sánchez Tinajero Á; Martínez Orozco JA; Becerril Vargas E; Dolores De la Merced A; Ruíz Santillán DP; Delgado Cueva AI; Alvarado Peña N
Am J Case Rep; 2021 Mar; 22():e929489. PubMed ID: 33743006
[TBL] [Abstract][Full Text] [Related]
11. Clinical Patterns and Morphology of COVID-19 Dermatology.
Agnihothri R; Fox LP
Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous signs in COVID-19 patients: A review.
Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations of Coronavirus Disease 2019.
Ghafoor R; Ali SM; Goldust M
J Cosmet Dermatol; 2022 Sep; 21(9):3667-3672. PubMed ID: 35866336
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information.
Burger B; Rodrigues HG
Adv Exp Med Biol; 2021; 1327():119-127. PubMed ID: 34279833
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.
Sachdeva M; Gianotti R; Shah M; Bradanini L; Tosi D; Veraldi S; Ziv M; Leshem E; Dodiuk-Gad RP
J Dermatol Sci; 2020 May; 98(2):75-81. PubMed ID: 32381430
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
19. Follicular eruption as a cutaneous manifestation in COVID-19.
Danarti R; Budiarso A; Rini DLU; Soebono H
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122237
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Manifestations in Patients with SARS-CoV-2 Infections.
Petrakis V; Panagopoulos P; Terzi I; Papazoglou D
Acta Dermatovenerol Croat; 2022 Dec; 30(4):216-219. PubMed ID: 36919387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
